Ke-jing Zhang
P.R. China
Changsha, 410008, China
Changsha, 410008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
LncRNA TYMSOS facilitates breast cancer metastasis and immune escape through downregulating ULBP3.
Journal: iScience
Published: May 10, 2023
YAP1/MMP7/CXCL16 axis affects efficacy of neoadjuvant chemotherapy via tumor environment immunosuppression in triple-negative breast cancer.
Journal: Gland surgery
Published: August 05, 2021
lncRNA MIR503HG inhibits cell proliferation and promotes apoptosis in TNBC cells via the miR-224-5p/HOXA9 axis.
Journal: Molecular therapy oncolytics
Published: October 11, 2020
Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p/OTX1 axis.
Journal: Cancer cell international
Published: May 07, 2020
LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.
Journal: Bioscience reports
Published: March 03, 2020
miR‑574‑5p attenuates proliferation, migration and EMT in triple‑negative breast cancer cells by targeting BCL11A and SOX2 to inhibit the SKIL/TAZ/CTGF axis.
Journal: International journal of oncology
Published: July 16, 2019
The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription.
Journal: Molecular oncology
Published: June 23, 2019
Relative dose intensity and therapy efficacy in different breast cancer molecular subtypes: a retrospective study of early stage breast cancer patients treated with neoadjuvant chemotherapy.
Journal: Breast cancer research and treatment
Published: December 27, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026